Ravi Yang Sarin - Director at Oncology Institute, Inc.

Issuer-level insider activity

Role
Director
Issuer ticker
TOI, TOIIW on Nasdaq, DFPH on OTC
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Ravi Yang Sarin since 18 Aug 2025

Reported holdings for Ravi Yang Sarin in Oncology Institute, Inc.

Form 4 holding Director

Oncology Institute, Inc.

Security class
Common stock
Shares / value
4,109,771
Estimated value
$8,671,617
Report date
17 Mar 2023
Price
$2.11
Ownership
LLC
Form 4 holding Director

Oncology Institute, Inc.

Security class
Common stock
Shares / value
75,427
Estimated value
$159,151
Report date
17 Mar 2023
Price
$2.11
Ownership
Direct

Transaction history for Ravi Yang Sarin in Oncology Institute, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .